Conquering Diseases

Long Term Follow-up Study for Multiple Sclerosis Patients who Completed the Alemtuzumab Extension Study

Description

Seeking men and women with Multiple Sclerosis who completed the alemtuzumab Extension study for a new study of the long-term safety and effectiveness of alemtuzumab.

Overview

We studying the health of multiple sclerosis patients who have been taking alemtuzumab as part of earlier studies.

What we're hoping for

We want to study the long-term safety and effectiveness of alemtuzumab for multiple sclerosis patients

Additional Information

ClinicalTrials.gov Identifier: NCT02255656

 Principal Investigator

Peter  Riskind, MD

UMass Memorial Health Care

 Study Contact

Melissa  Adams

508-856-4676

melissa.adams.@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989